Addiction Science and Clinical Practice 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Healthcare staff's perspectives on long-acting injectable buprenorphine treatment: a qualitative interview study
CONCLUSIONS: LAIB may strengthen the enabling environment in OAT for some patients by reducing clinic visits, exposure to risk environments, and the pressure to divert medication. A continued discussion about the prerequisites and rationale for LAIB implementation is needed in policy and practice.PMID:38581022 | DOI:10.1186/s13722-024-00458-6 (Source: Addiction Science and Clinical Practice)
Source: Addiction Science and Clinical Practice - April 5, 2024 Category: Addiction Authors: Johan Nordgren Bodil Monwell Bj örn Johnson Nina Veetnisha Gunnarsson Andrea Johansson Capusan Source Type: research
Psychometric properties of the cannabis abuse screening test (CAST) in a sample of Moroccans with cannabis use
CONCLUSION: The reliability, convergent validity, and discriminant validity tests all demonstrated that the Moroccan version of the CAST performed well and can be considered a valid tool for screening of problematic cannabis use.PMID:38570799 | PMC:PMC10988931 | DOI:10.1186/s13722-024-00459-5 (Source: Addiction Science and Clinical Practice)
Source: Addiction Science and Clinical Practice - April 3, 2024 Category: Addiction Authors: Hicham El Malki Salma Ghofrane Moutawakkil Abdelfettah El-Ammari Mohammed El Amine Ragala Jaouad El Hilaly Samir El Gnaoui Fatima El Houari Karima El Rhazi Btissame Zarrouq Source Type: research
Psychometric properties of the cannabis abuse screening test (CAST) in a sample of Moroccans with cannabis use
CONCLUSION: The reliability, convergent validity, and discriminant validity tests all demonstrated that the Moroccan version of the CAST performed well and can be considered a valid tool for screening of problematic cannabis use.PMID:38570799 | DOI:10.1186/s13722-024-00459-5 (Source: Addiction Science and Clinical Practice)
Source: Addiction Science and Clinical Practice - April 3, 2024 Category: Addiction Authors: Hicham El Malki Salma Ghofrane Moutawakkil Abdelfettah El-Ammari Mohammed El Amine Ragala Jaouad El Hilaly Samir El Gnaoui Fatima El Houari Karima El Rhazi Btissame Zarrouq Source Type: research
Cost of start-up activities to implement a community-level opioid overdose reduction intervention in the HEALing Communities Study
CONCLUSION: We identified three distinct CTH hiring models that affected start-up costs: hospital-academic (Massachusetts), university-academic (Kentucky and Ohio), and community-leveraged (New York). Hiring, training, and purchasing start-up costs were lowest in New York due to existing local infrastructure. Community-based implementation similar to the New York model may have lower start-up costs due to leveraging of existing infrastructure, relationships, and support from local health departments.PMID:38566249 | PMC:PMC10988809 | DOI:10.1186/s13722-024-00454-w (Source: Addiction Science and Clinical Practice)
Source: Addiction Science and Clinical Practice - April 2, 2024 Category: Addiction Authors: Iv án D Montoya Colleen Watson Arnie Aldridge Danielle Ryan Sean M Murphy Brenda Amuchi Kathryn E McCollister Bruce R Schackman Joshua L Bush Drew Speer Kristin Harlow Stephen Orme Gary A Zarkin Mathieu Castry Eric E Seiber Joshua A Barocas Benjamin P Li Source Type: research
Cost of start-up activities to implement a community-level opioid overdose reduction intervention in the HEALing Communities Study
CONCLUSION: We identified three distinct CTH hiring models that affected start-up costs: hospital-academic (Massachusetts), university-academic (Kentucky and Ohio), and community-leveraged (New York). Hiring, training, and purchasing start-up costs were lowest in New York due to existing local infrastructure. Community-based implementation similar to the New York model may have lower start-up costs due to leveraging of existing infrastructure, relationships, and support from local health departments.PMID:38566249 | DOI:10.1186/s13722-024-00454-w (Source: Addiction Science and Clinical Practice)
Source: Addiction Science and Clinical Practice - April 2, 2024 Category: Addiction Authors: Iv án D Montoya Colleen Watson Arnie Aldridge Danielle Ryan Sean M Murphy Brenda Amuchi Kathryn E McCollister Bruce R Schackman Joshua L Bush Drew Speer Kristin Harlow Stephen Orme Gary A Zarkin Mathieu Castry Eric E Seiber Joshua A Barocas Benjamin P Li Source Type: research
Project CHARIOT: study protocol for a hybrid type 1 effectiveness-implementation study of comprehensive tele-harm reduction for engagement of people who inject drugs in HIV prevention services
The objectives are: (1) to determine if the C-THR intervention increases engagement in HIV prevention (i.e., HIV pre-exposure prophylaxis; PrEP or medications for opioid use disorder; MOUD) compared to non-SSP clinic referral and patient navigation, (2) to examine the long-term effectiveness and cost-effectiveness of the C-THR intervention, and (3) to assess the barriers and facilitators to implementation and sustainment of the C-THR intervention. The co-primary outcomes are PrEP or MOUD engagement across follow-up at 3, 6, 9 and 12 months. For PrEP, engagement is confirmed by tenofovir on dried blood spot or cabotegravir ...
Source: Addiction Science and Clinical Practice - March 26, 2024 Category: Addiction Authors: Tyler S Bartholomew Marina Plesons David P Serota Elizabeth Alonso Lisa R Metsch Daniel J Feaster Jessica Ucha Edward Suarez David W Forrest Teresa A Chueng Katrina Ciraldo Jimmie Brooks Justin D Smith Joshua A Barocas Hansel E Tookes Source Type: research
Hospitalization is a missed opportunity for HIV screening, pre-exposure prophylaxis, and treatment
DISCUSSION: We observed poor provision of HIV testing, PrEP and other HIV services for hospitalized PWID across multiple U.S. medical centers. Future initiatives should focus on providing this group with comprehensive HIV testing and treatment services through a status neutral approach.PMID:38528590 | PMC:PMC10964564 | DOI:10.1186/s13722-024-00451-z (Source: Addiction Science and Clinical Practice)
Source: Addiction Science and Clinical Practice - March 26, 2024 Category: Addiction Authors: William Bradford Hana Akselrod John Bassler Kelly W Gagnon Greer Burkholder Joseph Edward Carpenter Alaina Steck Jillian Catalanotti Irene Kuo Keanan McGonigle William Mai Melissa Notis Christopher Brokus Sarah Kattakuzhy Elana Rosenthal Ellen F Eaton Source Type: research
Project CHARIOT: study protocol for a hybrid type 1 effectiveness-implementation study of comprehensive tele-harm reduction for engagement of people who inject drugs in HIV prevention services
The objectives are: (1) to determine if the C-THR intervention increases engagement in HIV prevention (i.e., HIV pre-exposure prophylaxis; PrEP or medications for opioid use disorder; MOUD) compared to non-SSP clinic referral and patient navigation, (2) to examine the long-term effectiveness and cost-effectiveness of the C-THR intervention, and (3) to assess the barriers and facilitators to implementation and sustainment of the C-THR intervention. The co-primary outcomes are PrEP or MOUD engagement across follow-up at 3, 6, 9 and 12 months. For PrEP, engagement is confirmed by tenofovir on dried blood spot or cabotegravir ...
Source: Addiction Science and Clinical Practice - March 26, 2024 Category: Addiction Authors: Tyler S Bartholomew Marina Plesons David P Serota Elizabeth Alonso Lisa R Metsch Daniel J Feaster Jessica Ucha Edward Suarez David W Forrest Teresa A Chueng Katrina Ciraldo Jimmie Brooks Justin D Smith Joshua A Barocas Hansel E Tookes Source Type: research
Hospitalization is a missed opportunity for HIV screening, pre-exposure prophylaxis, and treatment
DISCUSSION: We observed poor provision of HIV testing, PrEP and other HIV services for hospitalized PWID across multiple U.S. medical centers. Future initiatives should focus on providing this group with comprehensive HIV testing and treatment services through a status neutral approach.PMID:38528590 | PMC:PMC10964564 | DOI:10.1186/s13722-024-00451-z (Source: Addiction Science and Clinical Practice)
Source: Addiction Science and Clinical Practice - March 26, 2024 Category: Addiction Authors: William Bradford Hana Akselrod John Bassler Kelly W Gagnon Greer Burkholder Joseph Edward Carpenter Alaina Steck Jillian Catalanotti Irene Kuo Keanan McGonigle William Mai Melissa Notis Christopher Brokus Sarah Kattakuzhy Elana Rosenthal Ellen F Eaton Source Type: research
Project CHARIOT: study protocol for a hybrid type 1 effectiveness-implementation study of comprehensive tele-harm reduction for engagement of people who inject drugs in HIV prevention services
The objectives are: (1) to determine if the C-THR intervention increases engagement in HIV prevention (i.e., HIV pre-exposure prophylaxis; PrEP or medications for opioid use disorder; MOUD) compared to non-SSP clinic referral and patient navigation, (2) to examine the long-term effectiveness and cost-effectiveness of the C-THR intervention, and (3) to assess the barriers and facilitators to implementation and sustainment of the C-THR intervention. The co-primary outcomes are PrEP or MOUD engagement across follow-up at 3, 6, 9 and 12 months. For PrEP, engagement is confirmed by tenofovir on dried blood spot or cabotegravir ...
Source: Addiction Science and Clinical Practice - March 26, 2024 Category: Addiction Authors: Tyler S Bartholomew Marina Plesons David P Serota Elizabeth Alonso Lisa R Metsch Daniel J Feaster Jessica Ucha Edward Suarez David W Forrest Teresa A Chueng Katrina Ciraldo Jimmie Brooks Justin D Smith Joshua A Barocas Hansel E Tookes Source Type: research
Hospitalization is a missed opportunity for HIV screening, pre-exposure prophylaxis, and treatment
DISCUSSION: We observed poor provision of HIV testing, PrEP and other HIV services for hospitalized PWID across multiple U.S. medical centers. Future initiatives should focus on providing this group with comprehensive HIV testing and treatment services through a status neutral approach.PMID:38528590 | PMC:PMC10964564 | DOI:10.1186/s13722-024-00451-z (Source: Addiction Science and Clinical Practice)
Source: Addiction Science and Clinical Practice - March 26, 2024 Category: Addiction Authors: William Bradford Hana Akselrod John Bassler Kelly W Gagnon Greer Burkholder Joseph Edward Carpenter Alaina Steck Jillian Catalanotti Irene Kuo Keanan McGonigle William Mai Melissa Notis Christopher Brokus Sarah Kattakuzhy Elana Rosenthal Ellen F Eaton Source Type: research
Project CHARIOT: study protocol for a hybrid type 1 effectiveness-implementation study of comprehensive tele-harm reduction for engagement of people who inject drugs in HIV prevention services
The objectives are: (1) to determine if the C-THR intervention increases engagement in HIV prevention (i.e., HIV pre-exposure prophylaxis; PrEP or medications for opioid use disorder; MOUD) compared to non-SSP clinic referral and patient navigation, (2) to examine the long-term effectiveness and cost-effectiveness of the C-THR intervention, and (3) to assess the barriers and facilitators to implementation and sustainment of the C-THR intervention. The co-primary outcomes are PrEP or MOUD engagement across follow-up at 3, 6, 9 and 12 months. For PrEP, engagement is confirmed by tenofovir on dried blood spot or cabotegravir ...
Source: Addiction Science and Clinical Practice - March 26, 2024 Category: Addiction Authors: Tyler S Bartholomew Marina Plesons David P Serota Elizabeth Alonso Lisa R Metsch Daniel J Feaster Jessica Ucha Edward Suarez David W Forrest Teresa A Chueng Katrina Ciraldo Jimmie Brooks Justin D Smith Joshua A Barocas Hansel E Tookes Source Type: research
Hospitalization is a missed opportunity for HIV screening, pre-exposure prophylaxis, and treatment
DISCUSSION: We observed poor provision of HIV testing, PrEP and other HIV services for hospitalized PWID across multiple U.S. medical centers. Future initiatives should focus on providing this group with comprehensive HIV testing and treatment services through a status neutral approach.PMID:38528590 | PMC:PMC10964564 | DOI:10.1186/s13722-024-00451-z (Source: Addiction Science and Clinical Practice)
Source: Addiction Science and Clinical Practice - March 26, 2024 Category: Addiction Authors: William Bradford Hana Akselrod John Bassler Kelly W Gagnon Greer Burkholder Joseph Edward Carpenter Alaina Steck Jillian Catalanotti Irene Kuo Keanan McGonigle William Mai Melissa Notis Christopher Brokus Sarah Kattakuzhy Elana Rosenthal Ellen F Eaton Source Type: research
Project CHARIOT: study protocol for a hybrid type 1 effectiveness-implementation study of comprehensive tele-harm reduction for engagement of people who inject drugs in HIV prevention services
The objectives are: (1) to determine if the C-THR intervention increases engagement in HIV prevention (i.e., HIV pre-exposure prophylaxis; PrEP or medications for opioid use disorder; MOUD) compared to non-SSP clinic referral and patient navigation, (2) to examine the long-term effectiveness and cost-effectiveness of the C-THR intervention, and (3) to assess the barriers and facilitators to implementation and sustainment of the C-THR intervention. The co-primary outcomes are PrEP or MOUD engagement across follow-up at 3, 6, 9 and 12 months. For PrEP, engagement is confirmed by tenofovir on dried blood spot or cabotegravir ...
Source: Addiction Science and Clinical Practice - March 26, 2024 Category: Addiction Authors: Tyler S Bartholomew Marina Plesons David P Serota Elizabeth Alonso Lisa R Metsch Daniel J Feaster Jessica Ucha Edward Suarez David W Forrest Teresa A Chueng Katrina Ciraldo Jimmie Brooks Justin D Smith Joshua A Barocas Hansel E Tookes Source Type: research
Hospitalization is a missed opportunity for HIV screening, pre-exposure prophylaxis, and treatment
DISCUSSION: We observed poor provision of HIV testing, PrEP and other HIV services for hospitalized PWID across multiple U.S. medical centers. Future initiatives should focus on providing this group with comprehensive HIV testing and treatment services through a status neutral approach.PMID:38528590 | PMC:PMC10964564 | DOI:10.1186/s13722-024-00451-z (Source: Addiction Science and Clinical Practice)
Source: Addiction Science and Clinical Practice - March 26, 2024 Category: Addiction Authors: William Bradford Hana Akselrod John Bassler Kelly W Gagnon Greer Burkholder Joseph Edward Carpenter Alaina Steck Jillian Catalanotti Irene Kuo Keanan McGonigle William Mai Melissa Notis Christopher Brokus Sarah Kattakuzhy Elana Rosenthal Ellen F Eaton Source Type: research
